Literature DB >> 9211066

Lipoprotein glycation and its metabolic consequences.

T J Lyons1, A J Jenkins.   

Abstract

Glycation of lipoproteins is implicated in the development of the macro- and microvascular complications of diabetes, atherosclerosis in general, and other disease processes including aging. Enhanced glycation may have direct effects, and may also amplify the effects of oxidative stress on lipoproteins. Most studies have examined the effects of glycation of LDL, particularly with respect to its atherogenicity. Other lipoproteins are more difficult to study because their several apolipoproteins, being of varying age, are not uniformly exposed to glucose. Inhibition of the combined stresses of glycation and oxidation towards lipoproteins may have beneficial effects on health.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211066     DOI: 10.1097/00041433-199706000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  12 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

Review 2.  Clinical significance of the physicochemical properties of LDL in type 2 diabetes.

Authors:  P G Scheffer; T Teerlink; R J Heine
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

3.  Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.

Authors:  B E Brown; R T Dean; M J Davies
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

4.  Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf).

Authors:  Maria Felice Brizzi; Patrizia Dentelli; Marzia Pavan; Arturo Rosso; Roberto Gambino; Maria Grazia De Cesaris; Giovanni Garbarino; Giovanni Camussi; Gianfranco Pagano; Luigi Pegoraro
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Lipid profiles and oxidative stress parameters in male and female hemodialysis patients.

Authors:  A Osorio; E Ortega; T de Haro; J M Torres; P Sánchez; E Ruiz-Requena
Journal:  Mol Cell Biochem       Date:  2011-03-09       Impact factor: 3.396

6.  Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study.

Authors:  B K Kilhovd; A Juutilainen; S Lehto; T Rönnemaa; P A Torjesen; K F Hanssen; M Laakso
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

7.  Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis.

Authors:  Kikuo Isoda; Eduardo Folco; M Reza Marwali; Fumitaka Ohsuzu; Peter Libby
Journal:  Atherosclerosis       Date:  2007-12-27       Impact factor: 5.162

Review 8.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

9.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997

10.  Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins.

Authors:  B E Brown; F M Mahroof; N L Cook; D M van Reyk; M J Davies
Journal:  Diabetologia       Date:  2006-02-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.